PSMA PET成像的要点与陷阱实用指南
本文综述了前列腺特异性膜抗原(PSMA)靶向PET/CT的判读要点,讨论了临床可用PSMA靶向放射性示踪剂的生理分布、前列腺癌常见播散模式以及良恶性模拟病变,并回顾了标准化PSMA PET报告系统及PSMA在筛选适合PSMA靶向治疗患者中的作用。
要点
- PSMA靶向PET显像已取代传统方法用于前列腺癌患者的诊疗,并改善了治疗选择与实施。
- 判读PSMA PET/CT需掌握临床可用PSMA靶向放射性示踪剂的生理分布。
- 需识别前列腺癌常见播散模式及良性、恶性模拟病变,并熟悉标准化PSMA PET报告系统。
核心结论
- PSMA靶向PET显像已革新前列腺癌患者的诊疗,取代传统显像方法并改善治疗选择与实施。
- 本综述为新手判读者提供PSMA PET/CT判读概述及克服常见陷阱的要点。
研究设计与样本
- 综述类文章,检索范围未报告。
主要发现
- 讨论了临床可用PSMA靶向放射性示踪剂的生理分布。
- 讨论了前列腺癌常见播散模式以及前列腺癌的良性和恶性模拟病变。
- 回顾了标准化PSMA PET报告系统以及PSMA在选择适合PSMA靶向治疗患者中的作用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Prostate-specific membrane antigen (PSMA)-targeted PET agents have revolutionized the care of patients with prostate cancer, supplanting traditional methods of imaging prostate cancer, and improving the selection and delivery of therapies. This has led to a rapid expansion in both the number of PSMA PET scans performed and the imaging specialists required to interpret those scans. To aid those imagers and clinicians who are new to the interpretation of PSMA PET, this review provides an overview of the interpretation of PSMA PET/CT imaging and pearls for overcoming commonly encountered pitfalls. We discuss the physiologic distribution of the clinically available PSMA-targeted radiotracers, the commonly encountered patterns of prostate cancer spread, as well as the benign and malignant mimics of prostate cancer. Additionally, we review the standardized PSMA PET reporting systems and the role of PSMA in selecting appropriate patients for PSMA-targeted therapies.
引用
- Voter AF, Werner RA, Savas H, et al. A Practical Guide to the Pearls and Pitfalls of PSMA PET Imaging. Semin Nucl Med. 2023. PMID: 37980186. doi:10.1053/j.semnuclmed.2023.11.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。